TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.400
-0.080 (-5.41%)
At close: Jun 27, 2025, 4:00 PM
1.500
+0.100 (7.14%)
After-hours: Jun 27, 2025, 7:11 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $79.23 million as of June 27, 2025. Its market cap has decreased by -82.79% in one year.
Market Cap
79.23M
Enterprise Value
-72.03M
1-Year Change
-82.79%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $79.23M, a decrease of -77.94%. That is a compound annual growth rate of -31.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 83.75M | -51.24% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |